zenzedi dextroamphetamine sulfate tablet
INDICATIONS AND USAGE Zenzedi ® (Dextroamphetamine Sulfate Tablets, USP) is indicated for: 1. Narcolepsy . 2. Attention Deficit Disorder with Hyperactivity, as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 to 16 years) with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. The diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (soft) neurological signs, learning disability, and abnormal EEG may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted.
arbor pharmaceuticals, inc.
TRIANGLE GREEN MIA 7 5
MIA 7 5 TRIANGLE GREEN
Related Pills
zenzedi dextroamphetamine sulfate 5 mg
arbor pharmaceuticals, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Zenzedi (
DEXTROAMPHETAMINE SULFATE Tablets, USP) are available as: 2.5 mg: white, square tablet, debossed "2.5" on one side and "MIA" on the other side in: Bottles of 30 tablets, NDC 24338-850-03 5 mg: pink, oval tablet, debossed "5" on one side and "MIA" score on the other side in: Bottles of 30 tablets, NDC 24338-851-03 7.5 mg: Light green, triangle tablet, debossed "7.5" on one side and "MIA" on the other side in: Bottles of 30 tablets, NDC 24338-852-03 10 mg: peach, round tablet, double scored on one side and debossed "10" over "MIA" on the other side in: Bottles of 30 tablets, NDC 24338-853-03 15 mg: Light blue, pentagon tablet, debossed "15" on one side and "MIA" on the other side in: Bottles of 30 tablets, NDC 24338-854-03 20 mg: purple, capsule-shaped tablet, debossed "20" on one side and "MIA" on the other side in: Bottles of 30 tablets, NDC 24338-855-03 30 mg: Light yellow, hexagon tablet, debossed "30" on one side and "MIA" on the other side in: Bottles of 30 tablets, NDC 24338-856-03 Store at 20º to 25ºC (68º to 77ºF); excursions permitted 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
More pills like TRIANGLE MIA 7 5